A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor
- PMID: 19161279
- DOI: 10.1021/jm8014052
A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor
Abstract
The adenosine receptor subfamily consists of the adenosine A(1), A(2A), A(2B), and A(3) receptors, which are localized in a variety of tissues throughout the human body. It is, therefore, a challenge to develop receptor specific ligands with improved tissue selectivity. Allosteric modulators could have these therapeutic advantages over orthosteric ligands. In the present study, a series of 2,4-disubstituted quinolines were synthesized on the basis of the structure of LUF6000 (34). Compound 27 (LUF6096) was able to allosterically enhance agonist binding to a similar extent as 34. In addition, this new compound showed low, if any, orthosteric affinity for any of the adenosine receptors. In a functional assay, compound 27 showed improved activity in comparison to 34, as it increased both the intrinsic efficacy and the potency of the reference agonist Cl-IB-MECA at the human adenosine A(3) receptor.
Similar articles
-
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.Biochem Pharmacol. 2011 Sep 15;82(6):658-68. doi: 10.1016/j.bcp.2011.06.017. Epub 2011 Jun 21. Biochem Pharmacol. 2011. PMID: 21718691 Free PMC article.
-
Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor.J Med Chem. 2006 Jun 1;49(11):3354-61. doi: 10.1021/jm060086s. J Med Chem. 2006. PMID: 16722654 Free PMC article.
-
Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor.J Med Chem. 2009 Apr 9;52(7):2098-108. doi: 10.1021/jm801659w. J Med Chem. 2009. PMID: 19284749 Free PMC article.
-
Allosteric properties of G protein-coupled receptor oligomers.Pharmacol Ther. 2007 Sep;115(3):410-8. doi: 10.1016/j.pharmthera.2007.06.004. Epub 2007 Jun 27. Pharmacol Ther. 2007. PMID: 17655934 Review.
-
Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.Mol Interv. 2009 Jun;9(3):125-35. doi: 10.1124/mi.9.3.6. Mol Interv. 2009. PMID: 19592673 Review.
Cited by
-
Allosteric modulation of purine and pyrimidine receptors.Adv Pharmacol. 2011;61:187-220. doi: 10.1016/B978-0-12-385526-8.00007-2. Adv Pharmacol. 2011. PMID: 21586360 Free PMC article. Review.
-
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.Biochem Pharmacol. 2011 Sep 15;82(6):658-68. doi: 10.1016/j.bcp.2011.06.017. Epub 2011 Jun 21. Biochem Pharmacol. 2011. PMID: 21718691 Free PMC article.
-
Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).Bioorg Med Chem. 2010 Aug 15;18(16):5995-6005. doi: 10.1016/j.bmc.2010.06.071. Epub 2010 Jun 25. Bioorg Med Chem. 2010. PMID: 20643554 Free PMC article.
-
Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology.Molecules. 2022 Jun 10;27(12):3742. doi: 10.3390/molecules27123742. Molecules. 2022. PMID: 35744872 Free PMC article.
-
Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.J Comput Chem. 2017 Jun 5;38(15):1209-1228. doi: 10.1002/jcc.24728. Epub 2017 Jan 28. J Comput Chem. 2017. PMID: 28130813 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases
